Chen YP, Chen A, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394:64–80.
Tseng M, Ho F, Leong YH, Wong LC, Tham IW, Cheo T, Lee AW. Emerging radiotherapy technologies and trends in nasopharyngeal cancer. Cancer Commun. 2020;40:395–405.
Tan LP, Tan GW, Sivanesan VM, Goh SL, Ng XJ, Lim CS, Kim WR, Mohidin T, Mohd DN, Ong SH, Wong CY, Sawali H, Yap YY, Hassan F, Pua KC, Koay CE, Ng CC, Khoo AS. Systematic comparison of plasma ebv dna, anti-ebv antibodies and mirna levels for early detection and prognosis of nasopharyngeal carcinoma. Int J Cancer. 2020;146:2336–47.
Article CAS PubMed Google Scholar
Wang YQ, Zhang Y, Jiang W, Chen YP, Xu SY, Liu N, Zhao Y, Li L, Lei Y, Hong XH, Liang YL, Li JY, Zhang LL, Yun JP, Sun Y, Li YQ, Ma J. Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis. J Immunother Cancer. 2019;7:298.
Article PubMed PubMed Central Google Scholar
Zhang Z, Huang J, Wang G, Jin F, Zheng J, Xiao H, Lei L, Luo J, Chen C. Serum mirnas, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with ccrt. BMC Cancer. 2020;20:183.
Article CAS PubMed PubMed Central Google Scholar
Tan R, Phua S, Soong YL, Oon L, Chan KS, Lucky SS, Mong J, Tan MH, Lim CM. Clinical utility of epstein-barr virus dna and other liquid biopsy markers in nasopharyngeal carcinoma. Cancer Commun. 2020;40:564–85.
Li WZ, Liu GY, Lin LF, Lv SH, Qiang MY, Lv X, Wu YS, Liang H, Ke LR, Wang DL, Yu YH, Qiu WZ, Liu KY, Guo X, Li JP, Zou YJ, Xiang YQ, Xia WX. Mri-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: prognostic value and a nomogram for the pretherapy prediction of it. Radiother Oncol. 2020;145:101–8.
Article CAS PubMed Google Scholar
Liu W, Li H, Sheng H, Liu X, Chi P, Wang X, Mao M. A randomized controlled trial on evaluation of plasma epstein-barr virus biomarker for early diagnosis in patients with nasopharyngeal carcinoma. Adv Ther. 2020;37:4280–90.
Article CAS PubMed Google Scholar
Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis. 2008;8:53.
Pauker SG, Kassirer JP. The threshold approach to clinical decision making. New Engl J Med. 1980;302:1109–17.
Article CAS PubMed Google Scholar
Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252–9.
Article CAS PubMed Google Scholar
Guan S, Wei J, Huang L, Wu L. Chemotherapy and chemo-resistance in nasopharyngeal carcinoma. Eur J Med Chem. 2020;207: 112758.
Article CAS PubMed Google Scholar
Hao W, Wu L, Cao L, Yu J, Ning L, Wang J, Lin X, Chen Y. Radioresistant nasopharyngeal carcinoma cells exhibited decreased cisplatin sensitivity by inducing slc1a6 expression. Front Pharmacol. 2021;12: 629264.
Article CAS PubMed PubMed Central Google Scholar
Du T, Jiang J, Chen Y, Zhang N, Chen G, Wang X, Long X, Feng X. Mir-138-1-3p alters the stemness and radiosensitivity of tumor cells by targeting cripto and the jak2/stat3 pathway in nasopharyngeal carcinoma. Ann Transl Med. 2021;9:485.
Article CAS PubMed PubMed Central Google Scholar
Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, Levi F, Lidereau R, Nogues C, Mira JP, Chompret A, Joulin V, Clavel-Chapelon F, Bourhis J, Andre F, Delaloge S, Tursz T, Kroemer G, Zitvogel L. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007;13:1050–9.
Article CAS PubMed Google Scholar
Chen L, Flies DB. Molecular mechanisms of t cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013;13:227–42.
Article PubMed PubMed Central Google Scholar
Zhang N, Hu C. Effect of pd-l1 and tumor regression rate on prognosis of nasopharyngeal carcinoma. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020;45:1276–82.
Adkins DR, Haddad RI. Clinical trial data of anti-pd-1/pd-l1 therapy for recurrent or metastatic nasopharyngeal carcinoma: a review. Cancer Treat Rev. 2022;109: 102428.
Article CAS PubMed Google Scholar
Zhou Y, Shi D, Miao J, Wu H, Chen J, Zhou X, Hu D, Zhao C, Deng W, Xie C. Pd-l1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of pd-1 and ebv-dna load. Sci Rep-UK. 2017;7:43627.
Xu XF, Lu RQ, Xiao R, Zhou L, Zhao XM, Hu XC, Gao X, Guo L. Rta-igg as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma. Cancer Biomark. 2016;16:467–76.
Article CAS PubMed Google Scholar
Yan Y, Yang X, Sun X, Zhang H, Liu L, Ran R. Inhibitory effect of simiao qingwen baidu decoction on epstein-barr virus ea, vca expression and dna replication in vitro. Biomed Pharmacother. 2020;131: 110638.
Article CAS PubMed Google Scholar
Mikirova N, Hunninghake R. Effect of high dose vitamin c on epstein-barr viral infection. Med Sci Monitor. 2014;20:725–32.
Qu Y, Wang D, Yang L, Liu HY, Cui W, Che YQ. Expression and clinical significance of programmed death ligand 1 in nasopharyngeal carcinoma. Mol Clin Oncol. 2018;9:75–81.
CAS PubMed PubMed Central Google Scholar
Del RM, Buhler L, Gibbons C, Tian J, Rodriguez-Barbosa JI. Pd-1/pd-l1, pd-1/pd-l2, and other co-inhibitory signaling pathways in transplantation. Transpl Int. 2008;21:1015–28.
Long M, Fu Z, Li P, Nie Z. Cigarette smoking and the risk of nasopharyngeal carcinoma: a meta-analysis of epidemiological studies. BMJ Open. 2017;7: e16582.
Yang M, Huang W. Circular rnas in nasopharyngeal carcinoma. Clin Chim Acta. 2020;508:240–8.
Article CAS PubMed Google Scholar
Tsao SW, Tsang CM, Lo KW. Epstein-barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc B. 2017;372:20160270.
留言 (0)